SUBSCRIBE
SUBSCRIBE

Obesity Pill Shows Promise, University of Copenhagen Study

October 23, 2008 | 
1 min read

LONDON (Reuters) - People taking NeuroSearch A/S’s obesity pill tesofensine lost twice as much weight as men and women using approved weight loss drugs, Danish researchers said on Thursday.

Europe
MORE ON THIS TOPIC
European Union flags in front of the blurred European Parliament in Brussels, Belgium
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
April 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing large scissors cutting employees in half
Layoffs
The 5 Largest Biopharma Layoffs of Q1 2025
April 10, 2025
 · 
5 min read
 · 
Angela Gabriel
Courtesy of Sarepta Therapeutics
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
April 4, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
March 28, 2025
 · 
2 min read
 · 
Dan Samorodnitsky